Trademark Details For ILLINOIS RPHARM (Serial Number 85768202)

  •  Home
  •  Print
ILLINOIS RPHARM
2
3
3
0
Serial Number  United States - USPTO 85768202
Registration Number 4342673
Mark
ILLINOIS RPHARM
Filing Date Oct-31-2012
Status
Registered  
REGISTERED A.. (800)
REGISTERED AND RENEWED
Attorney Name
TTAB
0



  • Mark Literal Elements:
  • Description Of Mark:
  • Color(s) Claimed:
  • Disclaimer:

041Education and entertainment

U.S Class(es): 100, 101, 107

Class Status: Active

First Use: Aug-02-2010

First Use in Commerce: Aug-02-2010


19.13.01
27.03.05



Correspondences

NameAndrew L. Goldstein
AddressFREEBORN & PETERS LLP Suite 3000 311 S Wacker Dr. CHICAGO IL 60606-6679

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Nov-03-2012NEW APPLICATION ENTERED   NWAPI
Nov-06-2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Nov-07-2012NOTICE OF DESIGN SEARCH CODE MAILED   MDSMO
Jan-16-2013ASSIGNED TO EXAMINER   DOCKD
Jan-23-2013EXAMINERS AMENDMENT -WRITTEN   CNEAR
Jan-23-2013EXAMINER'S AMENDMENT ENTERED   XAECI
Jan-23-2013EXAMINER'S AMENDMENT MAILED   CNEAF
Jan-23-2013APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Jan-25-2013ASSIGNED TO LIE   ALIEA
Feb-05-2013LAW OFFICE PUBLICATION REVIEW COMPLETED   PREVO
Feb-20-2013NOTICE OF PUBLICATION   NPUBO
Mar-12-2013PUBLISHED FOR OPPOSITION   PUBOA
May-28-2013REGISTERED-PRINCIPAL REGISTER   R.PRA
Mar-15-2019TEAS SECTION 8 & 15 RECEIVED   E815I
Apr-19-2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Apr-19-2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Apr-19-2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED   NA85E
May-28-2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED   REM2E
Dec-06-2022TEAS SECTION 8 & 9 RECEIVED   E89RI
Jul-01-2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Jul-01-2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Jul-01-2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)   RNL1Q
Jul-01-2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED   NA89E